Income Taxes (Tables)
|
12 Months Ended |
Dec. 31, 2023 |
| Income Tax Disclosure [Abstract] |
|
| Schedule of (Income) Loss Before Income Taxes |
The following table presents the loss (income) before income taxes for the periods presented (in thousands): | | | | | | | | | | | | | | | | | | | | | | | For the Year Ended December 31, | | | 2023 | | 2022 | | 2021 | | Loss (income) attributable to common stockholders | | $ | 1,617,188 | | | $ | (175,668) | | | $ | 70,152 | | Loss attributable to noncontrolling interest and redeemable noncontrolling interests | | 1,078,344 | | | 1,023,022 | | | 901,107 | | | Loss before income taxes | | $ | 2,695,532 | | | $ | 847,354 | | | $ | 971,259 | |
|
| Schedule of Income Tax (Benefit) Provision |
The income tax (benefit) provision consists of the following (in thousands): | | | | | | | | | | | | | | | | | | | | | | | For the Year Ended December 31, | | | 2023 | | 2022 | | 2021 | Current | | | | | | | Federal | | $ | — | | | $ | — | | | $ | — | | State | | — | | | — | | | — | | | Foreign | | — | | | — | | | — | | | Total current (benefit) expense | | — | | | — | | | — | | Deferred | | | | | | | Federal | | (23,583) | | | 1,460 | | | 13,938 | | State | | 10,892 | | | 831 | | | (4,667) | | | Foreign | | — | | | — | | | — | | | Total deferred (benefit) provision | | (12,691) | | | 2,291 | | | 9,271 | | Total | | $ | (12,691) | | | $ | 2,291 | | | $ | 9,271 | |
|
| Schedule of Reconciliation of The Statutory Federal Rate |
The following table represents a reconciliation of the statutory federal rate and the Company’s effective tax rate for the periods presented: | | | | | | | | | | | | | | | | | | | | | | | For the Year Ended December 31, | | | 2023 | | 2022 | | 2021 | Tax provision (benefit) at federal statutory rate | | (21.00) | % | | (21.00) | % | | (21.00) | % | State income taxes, net of federal benefit | | (1.11) | | | 3.42 | | | (2.30) | | Effect of noncontrolling and redeemable noncontrolling interests | | 8.40 | | | 25.35 | | | 19.48 | | Stock-based compensation | | 0.46 | | | 1.03 | | | 0.29 | | | | | | | | | Tax credits | | (0.63) | | | (1.42) | | | (0.82) | | | Effect of valuation allowance | | 4.06 | | | (7.47) | | | 4.67 | | Goodwill impairment | | 9.02 | | | — | | | — | | Other | | 0.33 | | | 0.36 | | | 0.63 | | Total | | (0.47) | % | | 0.27 | % | | 0.95 | % |
|
| Schedule of Deferred Tax Assets and Liabilities |
The following table represents the components of the Company’s deferred tax assets and liabilities for the periods presented (in thousands): | | | | | | | | | | | | | | | | | December 31, | | | 2023 | | 2022 | Deferred tax assets | | | | | Accruals and prepaids | | $ | 47,922 | | | $ | 39,942 | | Deferred revenue | | 81,692 | | | 70,491 | | Net operating loss carryforwards | | 788,507 | | | 625,147 | | Stock-based compensation | | 12,309 | | | 11,327 | | Investment tax and other credits | | 122,317 | | | 108,107 | | | Interest expense | | 125,332 | | | 16,386 | | | UNICAP costs | | 110,656 | | | 149,873 | | | | | | | | Total deferred tax assets | | 1,288,735 | | | 1,021,273 | | | Less: Valuation allowance | | (174,328) | | | (61,695) | | | Gross deferred tax assets | | 1,114,407 | | | 959,578 | | | Deferred tax liabilities | | | | | | Interest rate derivatives | | 16,945 | | | 20,613 | | | Capitalized costs to obtain a contract | | 375,226 | | | 266,697 | | | Fixed asset depreciation and amortization | | 580,569 | | | 442,656 | | | Deferred tax on investment in partnerships | | 264,537 | | | 362,659 | | | Gross deferred tax liabilities | | 1,237,277 | | | 1,092,625 | | | Net deferred tax liabilities | | $ | (122,870) | | | $ | (133,047) | |
|
| Schedule of Tax Years that Remain Open and Subject to Examination by the Tax Authorities |
The following table summarizes the tax years that remain open and subject to examination by the tax authorities in the most significant jurisdictions in which the Company operates: | | | | | | | Tax Years | | U.S. Federal | 2020 - 2023 | | State | 2019 - 2023 |
|